Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/12/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/12/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/10/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/10/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/10/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/10/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/09/25 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
3 | |
| 12/09/25 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
3 |
